SynOx is developing emactuzumab – a potential best-in-class, next-generation CSF1(R) inhibiting monoclonal antibody Provides flexible loan facility to support additional clinical work and activities to drive its successful registration and commercialisation Funding is additional to recent…

Medit i900 оснащен передовыми технологиями для более плавного, легкого сканирования, удобного управления и улучшения качества сканирования СЕУЛ, Южная Корея, и ЛОНГ-БИЧ, Калифорния, 30 апреля 2024 г. /PRNewswire/ — Компания Medit (www.medit.com), ведущий поставщик стоматологических…

VADUZ, Liechtenstein, April 30, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, reports many presentations including new RefluxStop™ real-world data from over 200 patients at five hospitals across Europe, were…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.